New U of C research examines commonly used toxinFebruary 27, 2008New Research at the University of Calgary, Faculty of Kinesiology suggests that Botulinium type-A toxin (BTX-A) passes easily to surrounding muscles and is more difficult to control once injected than many people suspect. The paper will be published in an upcoming issue of the Journal of Biomechanics and is posted on the journal's "In Press" website at: http://www.jbiomech.com. The research team was led by Dr. Walter Herzog, who received the American Society of Biomechanists' highest honour for research last year. Herzog says that the results are interesting and have relevance for consumers and physicians who use product made out of the toxin. "The injection doses used in this study are similar to those used in human injection protocols for the soleus muscle, both for spastic cerebral palsy in children and hemi-plegic adults secondary to stroke," says Herzog. Herzog's lab was trying to use the product in ongoing research that examines how muscle weakness contributes to joint degeneration. The idea was to use botulinium toxin as an agent to temporarily paralyze muscles. What they found is that the toxin they used passed easily into the surrounding muscles and weakened all the muscles in the area. "The main reason that this is significant," says Herzog, "is that many people believe that when Botox is injected into a single muscle it stays there. This research shows that it is not that easy to control. As therapeutic applications of BTX-A in humans increase, it is important that we understand more about the functional affects of this product which, at the end of the day, is a toxin." University of Calgary |
|||||||||||||||||||||
| Related Toxin Current Events and Toxin News Articles A reductionist approach to HIV research A major obstacle to HIV research is the virus's exquisite specialisation for its human host - meaning that scientists' traditional tools, like the humble lab mouse, can deliver only limited information. Knockouts in human cells point to pathogenic targets Whitehead researchers have developed a new type of genetic screen for human cells to pinpoint specific genes and proteins used by pathogens, according to their paper in Science. Insect Resistance to Bt Crops can be Predicted, Monitored, and Managed Since 1996, crop plants genetically modified to produce bacterial proteins that are toxic to certain insects, yet safe for people, have been planted on more than 200 million hectares worldwide. Designer molecule detects tiny amounts of cyanide, then glows A small molecule designed to detect cyanide in water samples works quickly, is easy to use, and glows under ultraviolet or "black" light. Clemson researchers say algae key to mass extinctionss Algae, not asteroids, were the key to the end of the dinosaurs, say two Clemson University researchers. Geologist James W. Castle and ecotoxicologist John H. Rodgers have published findings that toxin producing algae were a deadly factor in mass extinctions millions of years ago. Killer algae a key player in mass extinctions Supervolcanoes and cosmic impacts get all the terrible glory for causing mass extinctions, but a new theory suggests lowly algae may be the killer behind the world's great species annihilations. Scientists visualize assembly line gears in ribosomes, cell's protein factory Even as research on the ribosome, one of the cell's most basic machines, is recognized with a Nobel Prize, scientists continue to achieve new insights on the way ribosomes work. New guidelines identify best treatments to help ALS patients live longer, easier New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease. The guidelines are published in the October 13, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology. LSUHSC's England plays key role in developing new ALS treatment guidelines Dr. John England, Professor and Chairman of Neurology at LSU Health Sciences Center New Orleans, analyzed research findings and was responsible for the quality and accuracy of evidence analysis and the conclusions of the studies resulting in new guidelines for treating Lou Gehrig's disease, or amyotropic lateral sclerosis (ALS). Researchers find demand for cosmetic and surgical procedures in dermatologic surgery rising rapidly Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. More Toxin Current Events and Toxin News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||